Found 32 matching trials
Phase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal Metastases PHASE2 Approximately 40% of colorectal cancer patients will develop colorectal liv...
Show More Location
Severance Hospital, Yonsei University Health System
Learn More & Join Trial
Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma PHASE1 This study is designed to evaluate the efficacy and safety of sintilimab-be...
Show More Location
Multiple Locations
Learn More & Join Trial
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA PHASE1 The high-grade malignant brain tumors, glioblastoma multiforme (GBM) and an...
Show More Location
Lenox Hill Brain Tumor Center
Learn More & Join Trial
dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular Carcinoma NA This study intends to evaluate the efficacy and safety of drug-eluting tran...
Show More Location
Chinese PLA General hospital
Learn More & Join Trial
Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy PHASE2 The purpose of the study is to assessed the efficiency of treatment based o...
Show More Location
Institut Gustave Roussy
Learn More & Join Trial
Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab) PHASE1 The high-grade malignant brain tumors, glioblastoma multiforme (GBM) and an...
Show More Location
Lenox Hill Brain Tumor Center
Learn More & Join Trial
Clinical Efficacy of Transarterial Infusion Chemotherapy for Unresectable Colorectal Cancer NA This is a prospective, multicenter, randomized, open-label clinical trial. ...
Show More Location
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Learn More & Join Trial
TACE Combined With Bevacizumab in HCC (BCLC-B) Beyond Up-To-Seven Criteria PHASE2 The purpose of this study is to evaluate the efficacy and safety of transca...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Intra-Arterial Bevacizumab as an Adjunct to Middle Meningeal Artery Embolization for Chronic Subdural Hematoma PHASE1 This is a Phase 1, open-label, single-center, dose-escalation study evaluat...
Show More Location
Multiple Locations
Learn More & Join Trial
Low-dose Intra-arterial Bevacizumab for Edema and Radiation Necrosis Therapeutic Intervention (LIBERTI) PHASE2 To assess the overall safety and efficacy of intra-arterial (IA) bevacizuma...
Show More Location
University of Kentucky Medical Center
Learn More & Join Trial